Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Turn Therapeutics Inc.
Market Cap
$346.73M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$344.04M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$349.70M
Operating Margin
-154.73%
TTM Avg
-1296.11%
3Y Avg
-1345.68%
5Y Avg
-487.32%
Market Cap
$352.67M
Operating Margin
-1425.70%
TTM Avg
-1388.03%
3Y Avg
-1860.44%
5Y Avg
-9490.29%
Market Cap
$353.00M
Operating Margin
24.85%
TTM Avg
23.00%
3Y Avg
24.99%
5Y Avg
31.17%
Market Cap
$353.88M
Operating Margin
-130.65%
TTM Avg
-155.28%
3Y Avg
-156.88%
5Y Avg
-129.07%
Market Cap
$355.36M
Operating Margin
8.14%
TTM Avg
7.82%
3Y Avg
7.35%
5Y Avg
9.95%
Market Cap
$355.43M
Operating Margin
0.00%
TTM Avg
-13402.79%
3Y Avg
-7027.62%
5Y Avg
-5128.57%
Market Cap
$359.53M
Operating Margin
-14.22%
TTM Avg
-4.51%
3Y Avg
-387.94%
5Y Avg
-2012.06%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | $346.73M | 0.00% | 0.00% | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -154.73% | -1296.11% | -1345.68% | -487.32% |
| Ocugen, Inc. (OCGN)vs › | $352.67M | -1425.70% | -1388.03% | -1860.44% | -9490.29% |
| Embecta Corp. (EMBC)vs › | $353.00M | 24.85% | 23.00% | 24.99% | 31.17% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | -130.65% | -155.28% | -156.88% | -129.07% |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 8.14% | 7.82% | 7.35% | 9.95% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | 0.00% | -13402.79% | -7027.62% | -5128.57% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | -14.22% | -4.51% | -387.94% | -2012.06% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -271.90% | -418.31% | -211.58% | -783.53% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-06-30 | 0.00% |
